BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18271875)

  • 1. Whole-genome profiling of chromosomal aberrations in hepatoblastoma using high-density single-nucleotide polymorphism genotyping microarrays.
    Suzuki M; Kato M; Yuyan C; Takita J; Sanada M; Nannya Y; Yamamoto G; Takahashi A; Ikeda H; Kuwano H; Ogawa S; Hayashi Y
    Cancer Sci; 2008 Mar; 99(3):564-70. PubMed ID: 18271875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping.
    Peiffer DA; Le JM; Steemers FJ; Chang W; Jenniges T; Garcia F; Haden K; Li J; Shaw CA; Belmont J; Cheung SW; Shen RM; Barker DL; Gunderson KL
    Genome Res; 2006 Sep; 16(9):1136-48. PubMed ID: 16899659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays.
    Yamamoto G; Nannya Y; Kato M; Sanada M; Levine RL; Kawamata N; Hangaishi A; Kurokawa M; Chiba S; Gilliland DG; Koeffler HP; Ogawa S
    Am J Hum Genet; 2007 Jul; 81(1):114-26. PubMed ID: 17564968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of allelic imbalances reveals 4q deletions as a poor prognostic factor and MDM4 amplification at 1q32.1 in hepatoblastoma.
    Arai Y; Honda S; Haruta M; Kasai F; Fujiwara Y; Ohshima J; Sasaki F; Nakagawara A; Horie H; Yamaoka H; Hiyama E; Kaneko Y
    Genes Chromosomes Cancer; 2010 Jul; 49(7):596-609. PubMed ID: 20461752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiles of a hepatoblastoma from a patient with Beckwith-Wiedemann syndrome with uniparental disomy on chromosome 11p15 and germline mutation of APC and PALB2.
    Kim SY; Jung SH; Kim MS; Han MR; Park HC; Jung ES; Lee SH; Lee SH; Chung YJ
    Oncotarget; 2017 Nov; 8(54):91950-91957. PubMed ID: 29190888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis.
    Kumon K; Kobayashi H; Namiki T; Tsunematsu Y; Miyauchi J; Kikuta A; Horikoshi Y; Komada Y; Hatae Y; Eguchi H; Kaneko Y
    Jpn J Cancer Res; 2001 Aug; 92(8):854-62. PubMed ID: 11509117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs.
    Slater HR; Bailey DK; Ren H; Cao M; Bell K; Nasioulas S; Henke R; Choo KH; Kennedy GC
    Am J Hum Genet; 2005 Nov; 77(5):709-26. PubMed ID: 16252233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
    Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
    J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and visualization of chromosomal abnormalities in SNP data with SNPscan.
    Ting JC; Ye Y; Thomas GH; Ruczinski I; Pevsner J
    BMC Bioinformatics; 2006 Jan; 7():25. PubMed ID: 16420694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
    Albrecht S; Hartmann W; Houshdaran F; Koch A; Gärtner B; Prawitt D; Zabel BU; Russo P; Von Schweinitz D; Pietsch T
    Int J Cancer; 2004 Sep; 111(4):627-32. PubMed ID: 15239143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas.
    Stejskalová E; Malis J; Snajdauf J; Pýcha K; Urbánková H; Bajciová V; Starý J; Kodet R; Jarosová M
    Cancer Genet Cytogenet; 2009 Oct; 194(2):82-7. PubMed ID: 19781440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomic imbalance and chromosome disorders in hepatoblastoma].
    Gao H; Zhang ZB; Ou YL; Zhang KR; Wang WL
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):915-9. PubMed ID: 17533743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma.
    Rumbajan JM; Maeda T; Souzaki R; Mitsui K; Higashimoto K; Nakabayashi K; Yatsuki H; Nishioka K; Harada R; Aoki S; Kohashi K; Oda Y; Hata K; Saji T; Taguchi T; Tajiri T; Soejima H; Joh K
    BMC Cancer; 2013 Dec; 13():608. PubMed ID: 24373183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma.
    Fransson S; Östensson M; Djos A; Javanmardi N; Kogner P; Martinsson T
    Int J Oncol; 2016 Mar; 48(3):1103-16. PubMed ID: 26794043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome DNA copy number changes identified by high density oligonucleotide arrays.
    Huang J; Wei W; Zhang J; Liu G; Bignell GR; Stratton MR; Futreal PA; Wooster R; Jones KW; Shapero MH
    Hum Genomics; 2004 May; 1(4):287-99. PubMed ID: 15588488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis.
    Nagano Y; Kim DH; Zhang L; White JA; Yao JC; Hamilton SR; Rashid A
    Endocr Relat Cancer; 2007 Jun; 14(2):483-92. PubMed ID: 17639061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
    Weber RG; Pietsch T; von Schweinitz D; Lichter P
    Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
    George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
    PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p57(KIP2) is not mutated in hepatoblastoma but shows increased transcriptional activity in a comparative analysis of the three imprinted genes p57(KIP2), IGF2, and H19.
    Hartmann W; Waha A; Koch A; Goodyer CG; Albrecht S; von Schweinitz D; Pietsch T
    Am J Pathol; 2000 Oct; 157(4):1393-403. PubMed ID: 11021841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
    Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
    Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.